李应龙,石家齐,陈方敏
LI Yinglong,SHI Jiaqi,CHEN Fangmin (1.Department of Interventional Radiology

• 1:贵州省人民医院放射介入科
• 2:贵阳医学院
• 3:贵阳医学院附院泌尿外科

摘要(Abstract)：

目的:探讨表皮生长因子受体(Epidermal growth factor receptor,EGFR)mRNA在膀胱移行细胞癌(transitional cell carcinoma,TCC)患者外周血中的表达及意义。方法:收集62例膀胱移行细胞癌患者外周静脉血及癌组织标本,提取总RNA,行RT-PCR,检测EGFR mRNA的表达。25例健康人外周静脉血标本作为对照。结果:62例膀胱TCC组织标本中,EGFR mRNA在组织中平均阳性率72.6%(45/62)。在Tis-1、T2、T3、T4期膀胱TCC患者组织中EGFR mRNA阳性率分别为57.1%、62.5%、85.7%、100%;在Tis-1、T2、T3、T4期膀胱TCC患者外周血中EGFR mRNA阳性率分别为14.3%、25.0%、78.6%、90.9%。在组织和外周血中低分期(Tis-1、T2)与高分期(T3、T4)膀胱TCC表达EGFR mRNA阳性率差异有显著性(P<0.01)。在25例健康人外周静脉血中均未发现EGFR mRNA的表达。结论:膀胱TCC组织及外周血中EGFR mRNA表达阳性率与肿瘤分期、是否转移呈相关性。RT-PCR法检测膀胱TCC患者外周血EGFR mRNA有望成为检测膀胱肿瘤细胞循环内微转移的有效方法。
Objective: To explore the expression of epidermal growth factor receptor(EGFR) mRNA in peripheral blood of patients with bladder transitional cell cancer(TCC) and its significance.Methods: Peripheral vein blood and tumor tissue samples of 62 patients with bladder TCC(group TCC) were collected and peripheral blood of 25 healthy subjects were collected as negative control(group C).The expression of EGFR mRNA was detected by RT-PCR.Results: The positive rates of EGFR mRNA expression averaged 72.6%(45/62) including 57.1%,62.5%,85.7%,and 100 % in tissue samples and 14.3%,25.0%,78.6%,and 90.9% in peripheral blood samples from group TCC of stages of Tis-1,T2,T3,and T4 respectively.There was a significant difference of EGFR mRNA expression in tissue and blood samples of TCC between stages Tis-1,T2 and stages T3,T4(P<0.01).EGFR mRNA was not detected in the 25 healthy people.Conclusion: Positive rates of EGFR mRNA expression in samples of tissue and peripheral blood were correlated with the staging and grading,and metastasis of TCC.RT-PCR might be one of the effective methods for detecting micrometastasis in circulating of bladder tumor cells.

关键词(KeyWords)： 膀胱肿瘤;逆转录聚合酶链式反应;受体,表皮生长因子;膀胱移行细胞癌;微转移
bladder neoplasms;reverse transcriptase polymerase chain reaction;receptor,epidermal growth factor;transitional cell of the bladder;micrometastasis

Abstract:

Keywords:

基金项目(Foundation): 国家教育部重点项目资助(207106);; 贵州省教育厅重点项目资助(黔科教2007027)

作者(Author): 李应龙,石家齐,陈方敏
LI Yinglong,SHI Jiaqi,CHEN Fangmin (1.Department of Interventional Radiology

DOI: 10.19367/j.cnki.1000-2707.2009.04.004

参考文献(References)：

• [1]顾方六,刘玉立.50年泌尿男生殖系肿瘤发病和构成情况的变迁[J].中华泌尿外科杂志,2002(23):88-90.
• [2]Mocellin S,Keilholz U,Rossi CR,et al.Circulatingtumor cells:the leukemic phase of solid cancers[J].Trends Mol Med,2006(3):130-139.
• [3]Gazzaniga P,GandiniO,GiulianiL,et al.Detection of epi-dermal growth factor receptor mRNA in peripheral blood:anew marker of circulating neoplastic cells in bladder canc-er patients[J].Clin Cancer Res,2001(7):577-583.
• [4]陈兵,王云海.胃癌患者外周血肿瘤细胞的检测及其临床意义[J].中华医学实践杂志,2004(6):509-511.
• [5]Mitsuhashi A,Tanaka N,Suzuka K,et al.Detection of epi-dermal growth factor receptor mRNAin peripheral blood ofcervical cancer patients[J].Gynecol Oncol,2003(89):480-485.
• [6]朱安义,史子敏.表皮生长因子受体在膀胱癌非肿瘤黏膜中的表达及意义[J].中华泌尿外科杂志,2006(27):43-45.
• [7]Neal DE,Sharp les L,Smith K,et al.The epidermalgrowth factor receptor and the prognosis of bladder cancer[J].Cancer April,1990(65):1619-1625.
• [8]严泽军,叶章群.LRIG1和EGFR在膀胱移行细胞癌中的表达及临床意义[J].临床泌尿外科杂志,2007(3):216-218.
• [9]王敬萍,郑华,李宝兰,等.EGFR基因突变与肺癌EG-FR-TK1获得性耐药的研究进展[J].实用临床医药杂志,2008(09):5.

文章评论(Comment)：